Quidel and Abbott Lead in POC Cardiac Markers

Quidel is the market leader in point-of-care (POC) cardiac markers, according to a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the top companies. The findings were reported in Kalorama Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics. Quidel is a market leader in rapid immunoassays and […]

IVDs Essential as U.S. Measles Cases Reach 27-Year High

There has been a milestone reached in 2019, but not one to celebrate. There are now more cases of measles in the United States than any time since 1992.  1,077 individual measles cases were confirmed as of June 2019, according to the Centers for Disease Control and Prevention (CDC). With doctors less familiar than they […]

Pfizer Zirabev Approval Sign of Growth Market for Biosimilars, Challenges for Cancer Drug Brands

News of an approval of a biosimilar for a major Roche cancer drug is, we think, evidence that U.S. biosimilars are a growth market opportunity.   At the same time, the approval is a growth limiter for booming cancer drug markets.  Pfizer Inc confirmed Friday that the the FDA approved its biosimilar to Avastin. Pfizer’s Zirabev […]

New Product Trends at ASMS 2019

The 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, held recently in Atlanta, Georgia, is a major showcase for mass spectrometry system (MS) introductions. Below are some of the trends evident among the many system launches. Small is Big Agilent Technologies introduced the LC/MSD iQ single quadrupole MS, measuring 12 x 18.7 in (305 […]

Will New HIV Recommendations Boost Test Volume?

From our partner publication LabPulse.com: New recommendations released June 11 from the U.S. Preventive Services Task Force (USPSTF) continue to strongly advise HIV screening for adolescents and adults, and for the first time they support preventive treatment for those at high risk. The guidance could boost volume for blood tests. Kalorama Information’s Infectious Disease World […]

Liquid Biopsy in 2019: Competitive and Growing

Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and […]

Cancer Therapeutics: The Targeting Advantage

The development of molecularly targeted cancer drugs is one of the most exciting advancements in oncology. The potential benefits from the identification of drug targets and the associated drugs and tests are illustrated by several novel examples, such as HER2/neu & Herceptin and Gleevec. The rising incidence of cancer, particularly in the over 50 population, […]

  • by Bruce Carlson
  • May 24, 2019
  • News

Are You Missing Out? 5 Exclusives and Scoops From Instrument Business Outlook

If you need to track instrument markets, and haven’t yet subscribed to Kalorama’s partner publisher Instrument Business Outlook (IBO), https://instrumentbusinessoutlook.com/product/instrument-business-outlook/ you could be missing out. Subscribers to IBO not only get the latest news, events and analysis in the analytical instrument industry delivered to their Inbox twice monthly, but they also receive the added benefit of IBO […]

  • by Bruce Carlson
  • May 13, 2019
  • News

Keep Up with CLIA Laboratory News and IVD Developments Daily with LabPulse.com

Kalorama Information’s publishing partner LabPulse.com recently started to present the voice of the laboratorian and present CLIA lab-related news.  Using Kalorama Information’s data sources and an editorial team dedicated to breaking news, the website provides a unique perspective on CLIA lab and IVD product developments. The site provides a forum for pathologists, laboratorians, business managers, […]

Blood tau test works as biomarker for deadly Creutzfeldt-Jakob disease

By Emily Hayes, LabPulse.com editor in chief FROM Kalorama’s partner publication Lab Pulse.com  Testing for the tau protein in blood could help predict the outlook for the rare and deadly Creutzfeldt-Jakob disease (CJD), a discovery that also has implications for research in Alzheimer’s disease and other neurodegenerative disorders, researchers reported in JAMA Neurology on May 6. Tau is […]